Melt Pharmaceuticals

Melt Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of patented non-intravenous and non-opioid sedation and analgesia medicines for short-duration medical procedures in outpatient and in-office settings. Melt’s core technology is a series of combination non-opioid sedation drug formulations that may replace or supplement current sedation modalities for more than 100 million medical procedures in the United States.

Melt Is Revolutionizing The Surgical Patient Experience

Melt Pharmaceuticals is developing a rapidly dissolving sublingual tablet, providing needle- and opioid-free procedural sedation and analgesia.

Needle- & Opioid-free

Our innovative, patented formulation has the potential to replace IV sedation in millions of short-duration medical procedures.